Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Cell Biol
1998 Oct 19;1432:283-95. doi: 10.1083/jcb.143.2.283.
Show Gene links
Show Anatomy links
Spindle checkpoint protein Xmad1 recruits Xmad2 to unattached kinetochores.
Chen RH
,
Shevchenko A
,
Mann M
,
Murray AW
.
???displayArticle.abstract???
The spindle checkpoint prevents the metaphase to anaphase transition in cells containing defects in the mitotic spindle or in chromosome attachment to the spindle. When the checkpoint protein Xmad2 is depleted from Xenopus egg extracts, adding Xmad2 to its endogenous concentration fails to restore the checkpoint, suggesting that other checkpoint component(s) were depleted from the extract through their association with Xmad2. Mass spectrometry provided peptide sequences from an 85-kD protein that coimmunoprecipitates with Xmad2 from egg extracts. This information was used to clone XMAD1, which encodes a homologue of the budding yeast (Saccharomyces cerevisiae) checkpoint protein Mad1. Xmad1 is essential for establishing and maintaining the spindle checkpoint in egg extracts. Like Xmad2, Xmad1 localizes to the nuclear envelope and the nucleus during interphase, and to those kinetochores that are not bound to spindle microtubules during mitosis. Adding an anti-Xmad1 antibody to egg extracts inactivates the checkpoint and prevents Xmad2 from localizing to unbound kinetochores. In the presence of excess Xmad2, neither chromosomes nor Xmad1 are required to activate the spindle checkpoint, suggesting that the physiological role of Xmad1 is to recruit Xmad2 to kinetochores that have not bound microtubules.
Figure 3. Excess Xmad2 inhibits sister chromatid segregation. Metaphase spindle and chromosomes were assembled in egg extracts treated with buffer (top, Control) or Xmad2 protein (100 ng/μl extract; bottom, Xmad2) as described in Materials and Methods. To initiate anaphase, calcium chloride was added and samples were taken immediately before (0′) or at the indicated times after calcium addition to visualize the nuclear (DNA) and spindle morphology (Spindle). The reduced microtubule intensity in the control experiment at 40 and 60 min reflects the reduced microtubule density typical of interphase extracts.
Figure 9. Anti-Xmad1 antibodies interfere with Xmad1 and Xmad2 binding to kinetochores. Metaphase chromosomes were assembled in egg extracts and treated with (B–D) or without (A) nocodazole. C and D, anti-Xmad1 and anti-Xmad2 antibodies, respectively, were added to the extracts 1 h before the addition of nocodazole. The chromosomes were isolated through a sucrose cushion and stained for Xmad1 and Xmad2. For D, Xmad2 staining is essentially the same if the anti-Xmad2 antibody was omitted during the immunofluorescent staining procedures (data not shown). Aggregates of chromosomes from several sperm nuclei are shown.
Figure 8. Xmad1 localized to unattached kinetochores during mitosis. Asynchronously growing XTC cells (A–E) or cells treated with nocodazole (F) were fixed in 3% paraformaldehyde and stained with affinity-purified mouse anti-Xmad1 and rabbit anti-Xmad2 antibodies as indicated on top. Texas red– conjugated anti–mouse and fluorescein-conjugated anti– rabbit IgG antibodies were used as secondary antibodies. The nuclei were viewed by staining with the DNA-binding dye Hoechst 33258 (DNA). The merges of all three fluorochromes are also shown (All). The cell cycle stages were determined by the morphology of the cell and its chromosomes. A, interphase; B, prophase; C, prometaphase; D, metaphase; E, anaphase; F, a nocodazole-arrested cell. Representative pictures of each cell type are shown.
Figure 1. Excess Xmad2 protein inhibits exit from mitosis in CSF-arrested extracts. (A) Immunoblot of Xmad2 in egg extracts (lane 1), in mock-depleted extracts (lane 2), and in Xmad2-depleted extracts (lane 3). Extracts shown in lanes 2 and 3 were used in the experiment shown in B. The migration of molecular size standards and Xmad2 is indicated on the left and right, respectively. (B) Autoradiogram of histone H1 kinase assay. Mock- or Xmad2-depleted CSF-arrested egg extracts were treated as indicated on the left: low 6H-Xmad2, recombinant 6H-Xmad2 protein supplemented to the level of endogenous protein; high 6H-Xmad2, 6H-Xmad2 added to 17-fold the concentration of endogenous protein. After 1 h of incubation on ice, sperm nuclei (10,000/μl) were added to all samples and incubated for 10 min at 23°C, followed by incubation with nocodazole (lower three panels) for another 10 min. The metaphase arrest was then released by the addition of calcium chloride to inactivate CSF activity. Aliquots were taken immediately before calcium was added (time 0) and every 15 min thereafter to determine Cdc2-associated histone H1 kinase activity. (C) Dose-dependent inhibition of Cdc2 inactivation by Xmad2. Xmad2 protein at the indicated concentrations (□, 0; ⋄, 25; ○, 50; ▵, 100 ng/μl of extract, respectively) was preincubated with CSF-arrested extracts, followed by incubation with sperm nuclei (500/μl) in the absence of nocodazole. H1 kinase assays were performed as described in B and incorporation of 32P into H1 was quantified using a PhosphorImager.
Figure 2. (A) Excess Xmad2 sustains Cdc2 activity by maintaining cyclin B levels in the absence of any nuclei and nocodazole. The addition of Xmad2 (100 ng/μl of extract), sperm nuclei (500/μl of extract), and/or nocodazole to CSF-arrested extracts is indicated on the left. Samples were taken for H1 kinase measurement and for cyclin B Western blots at the indicated times after calcium addition. (B) Excess Xmad2 arrests cycling extracts at the first mitosis. Eggs were activated in vitro to start the embryonic cell cycle and extracts were prepared. This cycling extract entered mitosis at 30 and 90 min upon incubation at 23°C (top) and became arrested at first mitosis in the presence of excess 6H-Xmad2 (bottom). Autoradiograms of H1 kinase assays are shown.
Figure 4. (A) Xmad2 associates with an 85-kD protein in CSF-arrested extracts. Immunoprecipitation was performed by using a control antibody (lanes 1 and 3) or an anti-Xmad2 antibody (lanes 2 and 4) as indicated. The immunoprecipitates were washed with a buffer containing 1% Triton X-100 (lanes 1 and 2) or 0.1% SDS (lanes 3 and 4). The proteins were resolved by SDS-PAGE and stained with Coomassie blue. The migration of p85, IgG, and Xmad2 is indicated on the left, and that of molecular weight standards on the right. (B) Sequencing of Xmad1. The unseparated pool of tryptic peptides recovered from the gel matrix was analyzed using a novel quadrupole TOF mass spectrometer. (a) Mass spectrum of the unseparated tryptic digest of the Xmad1 band. The peptide ions designated with T were in turn isolated by a quadrupole mass analyzer, fragmented in the collision cell, and then their tandem mass spectra were acquired with a reflector time-of-flight module. Peaks designated with asterisks are trypsin autolysis products. The peptide ion designated with A belongs to the antibody used in the purification of Xmad1. (b) Tandem mass spectrum of the doubly charged peptide ion T8 (marked with an arrow in a). Upon collisional fragmentation, tryptic peptides tend to produce a continuous series of fragment ions containing the COOH terminus (Y″ ions; Roepstorff and Fohlman, 1984). The peptide sequence (shown above) is deduced by considering precise mass differences between adjacent Y″ ions. M*, N-acetylated methionine sulfoxide amino acid residue. The spectrum also contains minor series of the NH2-terminal fragment ions (B ions) as well as internal fragment ions. Therefore to deduce the sequence with high confidence it is necessary to distinguish Y″ ions from the other ions in the spectrum. This has been achieved by selective isotopic labeling of the COOH-terminal carboxyl group of the peptides. (c) A zoom of the region in the tandem mass spectrum of T8 shows the principal of sequence readout of isotopically labeled peptides. Upon tryptic cleavage of the protein in a buffer containing H216O/H218O 1:1 (vol/vol) COOH-terminal carboxyl groups of peptide molecules incorporate 16O and 18O atoms in a 1:1 ratio. Thus the fragment ions containing the COOH terminus of the peptide (mostly Y″ ions) appear in the fragment spectrum as a characteristic isotopic pattern—a doublet split by 2 D. B ions or other fragment ions not containing COOH-terminal carboxyl group are observed as ions having normal isotopic pattern.
Figure 6. Xmad1 abundance is constant throughout the cell cycle. (A) Specificity of anti-Xmad1 antibodies in immunoblots of frog egg extracts (lanes E), frog cultured cells XTC (lanes X), and HeLa cells (lanes H). An affinity-purified anti-Xmad1 antibody (lanes 4–9) or the same antibody preblocked with recombinant Xmad1 protein (lanes 1–3) were used. Lanes 1–6, egg extracts or cell lysates. Lanes 7–12, anti-Xmad2 immunoprecipitates prepared from egg extracts or cell lysates were immunoblotted with anti-Xmad1 (lanes 7–9) or anti-Xmad2 (lanes 10–12) antibodies. (B) CSF-arrested extract (time 0) was incubated with calcium for the time indicated on top, and immunoblotted for Xmad1 (middle) or Xmad2 (bottom). Top, histone H1 kinase assay. (C) Immunoblots of cycling extracts using antibodies specific to Xmad1 (middle) or Xmad2 (bottom). Mitosis occurs at ∼50 and 120 min as determined by histone H1 kinase assay (top) and by the nuclear morphology (data not shown).
Figure 7. Xmad1 is important for establishing and maintaining the spindle checkpoint in frog egg extracts. (A) Xmad1 is important for spindle checkpoint function. CSF-arrested extracts were preincubated with a control antibody (IgG), an anti-Xmad1 antibody, or an anti-Xmad1 antibody preblocked with recombinant Xmad1 protein as indicated. Nocodazole and sperm nuclei were added to activate the spindle checkpoint for the lower three panels, whereas nocodazole was omitted for the top panel. H1 kinase activities were determined immediately before and at the indicated times after calcium addition as described in Fig. 1 B. (B) Xmad1 is required for maintaining the spindle checkpoint. The spindle checkpoint was first activated in CSF-arrested extracts with nocodazole and sperm nuclei followed by incubation with control (top), anti-Xmad1 (middle), or anti-Xmad2 (bottom) antibodies. H1 kinase activities were determined as in A.
Figure 10. Mitotic arrest induced by excess Xmad2 is independent of Xmad1. (A) Immunoblots of Xmad1 (top) and Xmad2 (bottom) in CSF-arrested extracts (lane 1), mock- (lane 2), Xmad1- (lane 3), or Xmad2-depleted (lane 4) extracts. (B) Excess Xmad2 can still induce a mitotic arrest in the absence of Xmad1. The extracts shown in lanes 2–4 of A were used. Top panels, extracts were incubated with sperm nuclei alone. Middle panels, nocodazole and sperm nuclei were added to activate the spindle checkpoint. Bottom panels, excess 6H-Xmad2 was added to the extracts in the absence of sperm nuclei and nocodazole. H1 kinase activities were determined before and at various times after calcium addition as described for Fig. 1 B.
Figure 11. A model for how Xmad1 and Xmad2 work to activate the spindle checkpoint. Binding of Xmad1 to unattached kinetochores enables its associated Xmad2 to interact with a downstream checkpoint component X. This interaction converts X into a form that is capable of directly or indirectly inhibiting the anaphase-promoting complex (APC). The interaction between Xmad2 and X is unstable when Xmad2 is not associated with kinetochores, so that the checkpoint is not activated without unattached kinetochores. Increasing the global Xmad2 concentration drives the complex formation by mass action even in the absence of kinetochores. At a high enough concentration of Xmad2, the level of Xmad2–X complex becomes comparable to that induced through kinetochore-associated Xmad2 and results in constitutive activation of the spindle checkpoint. A likely candidate for X is Cdc20.
Cahill,
Mutations of mitotic checkpoint genes in human cancers.
1998, Pubmed
Cahill,
Mutations of mitotic checkpoint genes in human cancers.
1998,
Pubmed
Chen,
Association of spindle assembly checkpoint component XMAD2 with unattached kinetochores.
1996,
Pubmed
,
Xenbase
Chen,
Characterization of spindle assembly checkpoint in Xenopus egg extracts.
1997,
Pubmed
,
Xenbase
Chen,
Nuclear localization and regulation of erk- and rsk-encoded protein kinases.
1992,
Pubmed
Cohen-Fix,
Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p.
1996,
Pubmed
,
Xenbase
Cohen-Fix,
The metaphase-to-anaphase transition: avoiding a mid-life crisis.
1997,
Pubmed
Dawson,
The Drosophila cell cycle gene fizzy is required for normal degradation of cyclins A and B during mitosis and has homology to the CDC20 gene of Saccharomyces cerevisiae.
1995,
Pubmed
Fang,
The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation.
1998,
Pubmed
,
Xenbase
Farr,
Bub1p kinase activates the Saccharomyces cerevisiae spindle assembly checkpoint.
1998,
Pubmed
Funabiki,
Cut2 proteolysis required for sister-chromatid seperation in fission yeast.
1996,
Pubmed
Glotzer,
Cyclin is degraded by the ubiquitin pathway.
1991,
Pubmed
,
Xenbase
Gorbsky,
Microinjection of antibody to Mad2 protein into mammalian cells in mitosis induces premature anaphase.
1998,
Pubmed
Hardwick,
Activation of the budding yeast spindle assembly checkpoint without mitotic spindle disruption.
1996,
Pubmed
Hardwick,
Mad1p, a phosphoprotein component of the spindle assembly checkpoint in budding yeast.
1995,
Pubmed
Hardwick,
The spindle checkpoint.
1998,
Pubmed
,
Xenbase
He,
The Schizosaccharomyces pombe spindle checkpoint protein mad2p blocks anaphase and genetically interacts with the anaphase-promoting complex.
1997,
Pubmed
He,
Mph1, a member of the Mps1-like family of dual specificity protein kinases, is required for the spindle checkpoint in S. pombe.
1998,
Pubmed
Hershko,
Methylated ubiquitin inhibits cyclin degradation in clam embryo extracts.
1991,
Pubmed
Hershko,
Roles of ubiquitin-mediated proteolysis in cell cycle control.
1997,
Pubmed
Holloway,
Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor.
1993,
Pubmed
,
Xenbase
Hoyt,
S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function.
1991,
Pubmed
Hwang,
Budding yeast Cdc20: a target of the spindle checkpoint.
1998,
Pubmed
Irniger,
Genes involved in sister chromatid separation are needed for B-type cyclin proteolysis in budding yeast.
1995,
Pubmed
Jin,
Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1.
1998,
Pubmed
Kallio,
Mammalian p55CDC mediates association of the spindle checkpoint protein Mad2 with the cyclosome/anaphase-promoting complex, and is involved in regulating anaphase onset and late mitotic events.
1998,
Pubmed
Kim,
Fission yeast Slp1: an effector of the Mad2-dependent spindle checkpoint.
1998,
Pubmed
King,
A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B.
1995,
Pubmed
,
Xenbase
Li,
Identification of a human mitotic checkpoint gene: hsMAD2.
1996,
Pubmed
Li,
Feedback control of mitosis in budding yeast.
1991,
Pubmed
Li,
MAD2 associates with the cyclosome/anaphase-promoting complex and inhibits its activity.
1997,
Pubmed
,
Xenbase
Li,
Mitotic forces control a cell-cycle checkpoint.
1995,
Pubmed
Minshull,
A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts.
1994,
Pubmed
,
Xenbase
Murone,
The fission yeast dma1 gene is a component of the spindle assembly checkpoint, required to prevent septum formation and premature exit from mitosis if spindle function is compromised.
1996,
Pubmed
Murray,
Cell cycle extracts.
1991,
Pubmed
Rieder,
The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores.
1995,
Pubmed
Roberts,
The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase.
1994,
Pubmed
Sagata,
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs.
1989,
Pubmed
,
Xenbase
Schwab,
Yeast Hct1 is a regulator of Clb2 cyclin proteolysis.
1997,
Pubmed
Shamu,
Sister chromatid separation in frog egg extracts requires DNA topoisomerase II activity during anaphase.
1992,
Pubmed
,
Xenbase
Shevchenko,
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.
1996,
Pubmed
Shevchenko,
Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer.
1997,
Pubmed
Sudakin,
The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis.
1995,
Pubmed
Surana,
Destruction of the CDC28/CLB mitotic kinase is not required for the metaphase to anaphase transition in budding yeast.
1993,
Pubmed
Takenaka,
MAP kinase is required for the spindle assembly checkpoint but is dispensable for the normal M phase entry and exit in Xenopus egg cell cycle extracts.
1997,
Pubmed
,
Xenbase
Taylor,
Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage.
1997,
Pubmed
Taylor,
The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase.
1998,
Pubmed
Visintin,
CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis.
1997,
Pubmed
Waters,
Localization of Mad2 to kinetochores depends on microtubule attachment, not tension.
1998,
Pubmed
Weiss,
The Saccharomyces cerevisiae spindle pole body duplication gene MPS1 is part of a mitotic checkpoint.
1996,
Pubmed
Wilm,
Analytical properties of the nanoelectrospray ion source.
1996,
Pubmed